Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Society for Psychosomatic Medicine (DGPM), the German Working Group of Anaphylaxis Training and Education (AGATE) and the patient organization German Allergy and Asthma Association (DAAB)

Allergo Journal International

Volumn 23, Issue 3, 2014, Pages 96-112

  Ring, Johannes ^a   Beyer, Kirsten ^b   Biedermann, Tilo ^c   Bircher, Andreas ^d   Duda, Dorothea ^e   Fischer, Jörg ^c   Friedrichs, Frank ^f   Fuchs, Thomas ^g   Gieler, Uwe ^h   Jakob, Thilo ⁱ   Klimek, Ludger ^j   Lange, Lars ^k   Merk, Hans F ^l   Niggemann, Bodo ^m   Pfaar, Oliver ^j   Przybilla, Bernhard ⁿ   Ruëff, Franziska ⁿ   Rietschel, Ernst ^o   Schnadt, Sabine ^p   Seifert, Roland ^q   Sitter, Helmut ^r   Varga, Eva Maria ^s   Worm, Margitta ^b   Brockow, Knut ^a   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f Pediatric Consultation Center Laurensberg   (Germany)

^g UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^h JUSTUS LIEBIG UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j UNIVERSITY OF MANNHEIM   (Germany)

^k ST MARIEN HOSPITAL   (Germany)

^l UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^m DRK KLINIKEN BERLIN WESTEND   (Germany)

ⁿ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^o UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^p German Allergy and Asthma Association   (Germany)

^q HANNOVER MEDICAL SCHOOL   (Germany)

^r PHILIPPS UNIVERSITY MARBURG   (Germany)

^s MEDICAL UNIVERSITY OF GRAZ   (Austria)

more..

Author keywords

Acute Urticaria; Anaphylactic Reaction; Laryngeal Tube; Mastocytosis; Omalizumab

Indexed keywords

EID: 85098804575     PISSN: None     EISSN: 21970378     Source Type: Journal    
DOI: 10.1007/s40629-014-0009-1     Document Type: Article

References (69)

1. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113: 832–836 DOI: 10.1016/j.jaci.2003.12.591
2. Ring J, Grosber M, Mührenschlager M, Brockow K. Anaphylaxis: acute treatment and management. Chem Immunol Allergy 2010; 95: 201–10 DOI: 10.1159/000315953
3. Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127: 587–593.e1-22 DOI: 10.1016/j.jaci.2011.01.038
4. Tryba M, Ahnefeld F, Barth J, Dick W, Doenicke A, Fuchs T et al. Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Allergo J 1994; 3: 211–222
5. Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs Th, Huttegger I et al. Emergency treatment of anaphylactic reactions. Allergo J 2007; 16: 420–434
6. Bresser H, Sander CH, Rakoski J. Emergencies by insect stings in Munich in 1992. Allergo J 1995; 4: 373–376
7. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children — a questionnaire-based survey in Germany. Allergy 2005; 60: 1440–1445 DOI: 10.1111/j.1398-9995.2005.00909.x
8. Portier P, Richet C. De l’action anaphylactique de certains venins. C R Soc Biol 1902; 54: 170
9. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A et al. Second symposium on the definition and management of anaphylaxis: summary report — Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391–397 DOI: 10.1016/j.jaci.2005.12.1303
10. Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy 2010; 95: 12–21 DOI: 10.1159/000315935
11. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443–451 DOI: 10.1111/j.1398-9995.2005.00785.x
12. Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 285–290 DOI: 10.1111/j.1365-2222.2004.01882.x
13. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122: 1161–1165 DOI: 10.1016/j.jaci.2008.09.043
14. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101: 139–143 DOI: 10.1258/jrsm.2008.070306
15. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol 2007; 120: 878–884 DOI: 10.1016/j.jaci.2007.07.040
16. Worm M, Edenharter G, Rueff F, Scherer K, Pföhler C, Mahler V et al. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 691–698 DOI: 10.1111/j.1398-9995.2012.02795.x
17. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66: 1072–1080 DOI: 10.1172/JCI109936
18. Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol 2013; 131: 144–149 DOI: 10.1016/j.jaci.2012.08.016
19. Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin Exp Allergy 2011; 41: 923–938 DOI: 10.1111/j.1365-2222.2011.03779.x
20. Ring J. Angewandte Allergologie. München: Urban & Vogel 2004
21. Rueff F, Przybilla B, Bilo MB, Müller U, Scheipl F, Aberer W et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047–1054 DOI: 10.1016/j.jaci.2009.08.027
22. Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226–232 DOI: 10.1111/j.1398-9995.2007.01569.x
23. Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G et al. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy 2010; 65: 919–923 DOI: 10.1111/j.1398-9995.2009.02302.x
24. Przybilla B, Ruëff F, Walker B, Räwer HC, Aberer W, Bauer CP et al. Diagnosis and therapy of bee and wasp venom allergy. Allergo J 2011; 20: 318–339
25. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G et al. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 857–871 DOI: 10.1111/j.1398-9995.2007.01421.x
26. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466–469 DOI: 10.1016/S0140-6736(77)91953-5
27. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986; 78: 76–83 DOI: 10.1016/0091-6749(86)90117-X
28. Commins SP, Platts-Mills TA. Anaphylaxis syndromes related to a new mammalian cross-reactive carbohydrate determinant. J Allergy Clin Immunol 2009; 124: 652–657 DOI: 10.1016/j.jaci.2009.08.026
29. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973; 52: 259–264 DOI: 10.1016/0091-6749(73)90044-4
30. Delage C, Irey NS. Anaphylactic deaths: a clinicopathologic study of 43 cases. J Forensic Sci 1972; 17: 525–540
31. Fisher MM. Clinical observations on the pathophysiology and treatment of anaphylactic cardiovascular collapse. Anaesth Intensive Care 1986; 14: 17–21
32. Pumphrey RS, Roberts IS. Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000; 53: 273–276 DOI: 10.1136/jcp.53.4.273
33. Krogh G von, Maibach HI. The contact urticaria syndrome — an updated review. J Am Acad Dermatol 1981; 5: 328–342 DOI: 10.1016/S0190-9622(81)70099-9
34. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 2002; 110: 341–348 DOI: 10.1067/mai.2002.126811
35. Morita E, Kunie K, Matsuo H. Food-dependent exercise-induced anaphylaxis. J Dermatol Sci 2007; 47: 109–117 DOI: 10.1016/j.jdermsci.2007.03.004
36. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144–1150 DOI: 10.1046/j.1365-2222.2000.00864.x
37. Mullins RJ, Dear KB, Tang ML. Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol 2009; 123: 689–693 DOI: 10.1016/j.jaci.2008.12.1116
38. Schwartz LB. Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders. Leuk Res 2001; 25: 553–562 DOI: 10.1016/S0145-2126(01)00020-0
39. Brockow K, Vieluf D, Püschel K, Grosch J, Ring J. Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. J Allergy Clin Immunol 1999; 104: 237–238 DOI: 10.1016/S0091-6749(99)70141-7
40. Nolan JP, Soar J, Zideman DA, Biarent D, Bossaert LL, Deakin C et al. European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010; 81: 1219–1276 DOI: 10.1016/j.resuscitation.2010.08.021
41. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005; 22: 272–273 DOI: 10.1136/emj.2005.023507
42. Simons FE, Schatz M. Anaphylaxis during pregnancy. J Allergy Clin Immunol 2012; 130: 597–606 DOI: 10.1016/j.jaci.2012.06.035
43. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000; 356: 2139–2143 DOI: 10.1016/S0140-6736(00)03495-4
44. Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510–524 DOI: 10.7326/0003-4819-142-7-200504050-00010
45. Gronemeyer. Noradrenalin statt Adrenalin beim anaphylaktischen Schock. Dtsch Med Wochenschr 1980, 102: 101
46. Hoffmann BB. Catecholamines, sympathomimetic drugs and adrenergic receptor anatagonists. In: Hardman JG, Limbird LE, Goodman A, eds. Goodman & Gilman’s. The pharmaceutical basis of therapeutics.NewYork: Mc Graw Hill, 2002
47. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008; 107: 620–624 DOI: 10.1213/ane.0b013e3181770b42
48. Meßmer K. Plasma substitutes and indications for their use. In: Tinker J, Rapin M, eds. Care of the critically ill patient. Berlin — Heidelberg — New York: Springer, 1983. S. 569–575 DOI: 10.1007/978-1-4471-3498-5_32
49. Stölting RK: Systemic circulation. Pharmacology & physiology in anesthetic practice. Philadelphia: J.B. Lippincott Company, 2006. S. 661–678
50. Walther A, Böttiger BW: Anaphylaktoide Reaktionen in der Prähospitalphase. Internist 2004; 45: 296–304 DOI: 10.1007/s00108-003-1142-y
51. Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013; 369: 1726–1734 DOI: 10.1056/NEJMra1208943
52. Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387–394 DOI: 10.1097/ALN.0b013e31827e5569
53. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901–1911 DOI: 10.1056/NEJMoa1209759
54. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007; 62: 830–837 DOI: 10.1111/j.1398-9995.2007.01435.x
55. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–1443 DOI: 10.1111/j.1398-9995.2009.02178.x
56. Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine — a survey of 68 clinical and 55 death cases. Forensic Sci Int 2006; 161: 189–197 DOI: 10.1016/j.forsciint.2006.01.019
57. Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 2000; 36: 462–468 DOI: 10.1016/S0196-0644(00)43749-2
58. Ring J, Rothenberger KH, Clauss W. Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 1985; 78: 9–14 DOI: 10.1159/000233854
59. Brockow K, Kiehn M, Riethmüller C, Vieluf D, Berger J, Ring J. Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997; 100: 458–463 DOI: 10.1016/S0091-6749(97)70135-0
60. Aouam K, Bouida W, Ben Fredj N, Chaabane A, Boubaker H, Boukef R et al. Severe ranitidine-induced anaphylaxis: a case report and literature review. J Clin Pharm Ther 2012; 37: 494–496 DOI: 10.1111/j.1365-2710.2011.01320.x
61. Winbery SL, Lieberman PL. Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol 2002; 17: 287–317
62. Choo KJ, Simons E, Sheikh A. Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2010; 65: 1205–1211 DOI: 10.1111/j.1398-9995.2010.02424.x
63. Fischer J, Biedermann T. Anaphylaxis due to allergological testing or therapy — a compact compendium for emergency management Allergo J 2009; 18: 124–131
64. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Asthma — Langfassung, 2. Aufl. Version 5. 2009, zuletzt geändert: August 2013 [cited: 26.02.2014]; http://www.versorgungsleitlinien.de/themen/asthma
65. Hartmann K, Biedermann T, Brockow K, Grabbe J, Horny H-P, Lippert U et al. Mastocytosis. Guideline of the German Society for Allergology an Clinical Immunology (DGAKI) and the German Society for Dermatology (DDG). Allergo J 2009; 18: 196–207
66. Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF et al. World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base. Int Arch Allergy Immunol 2013; 162: 193–204 DOI: 10.1159/000354543
67. Lieberman JA, Chehade M. Use of omalizumab in the treatment of food allergy and anaphylaxis. Curr Allergy Asthma Rep 2013; 13: 78–84 DOI: 10.1007/s11882-012-0316-x
68. Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F et al. Anaphylaxis school — a new educational program for tertiary prevention in patients with anaphylaxis. Allergo J 2012; 21: 96–102 DOI: 10.1007/s15007-012-0044-5
69. Fischer J, Kupfer J, Grosber M, Friedl T, Schallmeyer S, Rueff F, et al. Practical skills in the self therapy of anaphylaxis — development and evaluation of a test on decision making and prctical performance. Allergo J 2013; 22: 18–24 DOI: 10.1007/s15007-013-0014-6